Reduction of the concentration difference of proteins in biological liquids using a library of combinatorial ligands

The discovery of polypeptides and proteins with relevance to a particular biological state is complicated by their vast number and concentration range in most biological mixtures. Depletion methodologies are frequently used to remove the most abundant species; however, this removal not only fails significantly to enrich trace proteins, it may also nonspecifically deplete them due to their interactions with the removed high‐abundance proteins. Here we report a simple‐to‐use methodology that reduces the protein concentration range of a complex mixture like whole serum through the simultaneous dilution of high‐abundance proteins and the concentration of low‐abundance proteins. This methodology utilizes solid‐phase ligand libraries of immense diversity, generated by “split, couple, recombine” combinatorial chemistry, that are used for affinity‐based binding to the proteins of a given mixture. With a controlled sample‐to‐ligand ratio it is possible to modulate the relative concentration of proteins such that many peptides or proteins that are undetectable by classical analytical methods become easily accessible. The reduction in the dynamic range of unfractionated serum is specifically described along with treatment of other proteomes such as extracts from Escherichia coli, chicken egg white and cell culture supernatant. Mono‐ and bi‐dimensional electrophoresis (1‐DE and 2‐DE respectively) and surface‐enhanced laser desorption/ionization‐mass spectrometry (SELDI‐TOF‐MS) technology demonstrate the reduction in protein concentration range. Combining this approach with additional fractionation methods further increased the number of detectable species.

[1]  P. Cash,et al.  Enrichment of Escherichia coli proteins by column chromatography on reactive dye columns , 2003, Proteomics.

[2]  G. Baumbach,et al.  Chemically derived peptide libraries: a new resin and methodology for lead identification. , 2009, International journal of peptide and protein research.

[3]  Dr. Peter James.  Proteome Research: Mass Spectrometry , 2001, Principles and Practice.

[4]  R. Carbonell,et al.  Discovery of Alpha-1-Proteinase Inhibitor Binding Peptides from the Screening of a Solid Phase Combinatorial Peptide Library , 2000 .

[5]  B. Hambly,et al.  Separation of tumor necrosis factor α isoforms by two‐dimensional polyacrylamide gel electrophoresis , 1997, Electrophoresis.

[6]  Egisto Boschetti,et al.  Prefractionation techniques in proteome analysis: The mining tools of the third millennium , 2005, Electrophoresis.

[7]  D. Hochstrasser,et al.  The dynamic range of protein expression: A challenge for proteomic research , 2000, Electrophoresis.

[8]  Fang Wang,et al.  The human serum proteome: Display of nearly 3700 chromatographically separated protein spots on two‐dimensional electrophoresis gels and identification of 325 distinct proteins , 2003, Proteomics.

[9]  Sudhir Srivastava,et al.  The Early Detection Research Network Second Annual Scientific Workshop 14–16 October 2001, Seattle, Washington, USA , 2002, Disease markers.

[10]  R. Carbonell,et al.  Affinity purification of fibrinogen using a ligand from a peptide library. , 2002, Biotechnology and bioengineering.

[11]  K. Lam,et al.  A new type of synthetic peptide library for identifying ligand-binding activity , 1992, Nature.

[12]  Marc R. Wilkins,et al.  Proteome Research: New Frontiers in Functional Genomics , 1997, Principles and Practice.

[13]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.

[14]  F. Holsboer,et al.  Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry , 2004, Electrophoresis.

[15]  R. Carbonell,et al.  Affinity purification of von Willebrand factor using ligands derived from peptide libraries. , 1996, Bioorganic & medicinal chemistry.

[16]  L. Lomas,et al.  A simplified monobuffer multidimensional chromatography for high-throughput proteome fractionation. , 2005, Journal of chromatography. A.

[17]  R. Leatherbarrow,et al.  Studies on the mechanism of binding of serum albumins to immobilized cibacron blue F3G A. , 1980, The Biochemical journal.

[18]  P Berndt,et al.  Enrichment of low abundance proteins of Escherichia coli by hydroxyapatite chromatography , 1999, Electrophoresis.

[19]  Y. Yuki,et al.  Identification of low‐abundance proteins of bovine colostral and mature milk using two‐dimensional electrophoresis followed by microsequencing and mass spectrometry , 2002, Electrophoresis.

[20]  George M. Church,et al.  Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K‐12 , 1997, Electrophoresis.

[21]  D. Hochstrasser,et al.  Micropreparative two‐dimensional electrophoresis allowing the separation of samples containing milligram amounts of proteins , 1993, Electrophoresis.

[22]  R. B. Merrifield.  Automated synthesis of peptides. , 1965, Science.

[23]  M J Dunn,et al.  Zooming‐in on the proteome: Very narrow‐range immobilised pH gradients reveal more protein species and isoforms , 2001, Electrophoresis.

[24]  P. Davidsson,et al.  Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples , 2005, Proteomics.

[25]  Mary F. Lopez,et al.  Better approaches to finding the needle in a haystack: Optimizing proteome analysis through automation , 2000, Electrophoresis.

[26]  M. Wilchek,et al.  [1] Affinity chromatography , 1984 .

[27]  Á. Furka,et al.  General method for rapid synthesis of multicomponent peptide mixtures. , 2009, International journal of peptide and protein research.

[28]  Sang-Haeng Choi,et al.  Identifying the major proteome components of Helicobacter pylori strain 26695 , 2002, Electrophoresis.

[29]  S. Gygi,et al.  Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Andreas Wiesner,et al.  Detection of tumor markers with ProteinChip technology. , 2004, Current pharmaceutical biotechnology.